Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes-Reference-Cited by-同舟云学术

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

Published:2009-03 Issue:3 Volume:103 Page:280-290
ISSN:0035-9203
Container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene
language:en
Short-container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene

Author:

Balasegaram Manica,Young Heather,Chappuis François,Priotto Gerardo,Raguenaud Marie-Eve,Checchi Francesco

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Link

http://academic.oup.com/trstmh/article-pdf/103/3/280/5447009/103-3-280.pdf

Reference25 articles.

1. Eliminating human African trypanosomiasis: where do we stand and what comes next?;Simarro;PLoS Med,2008

2. Chemotherapy of human African trypanosomiasis: current and future prospects;Fairlamb;Trends Parasitol,2003

3. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis;Blum;Trop Med Int Health,2001

4. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda;Legros;Trans R Soc Trop Med Hyg,1999

5. Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda [in French];Legros;Bull Soc Pathol Exot,1999

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in transition-metal-catalyzed (Csp2)-X (X = Se, Te, As, Sb) bond formation;Molecular Catalysis;2024-03

2. Plant-Based Vaccines Against Human Parasitic Diseases;Natural Product Based Drug Discovery Against Human Parasites;2023

3. Rudimentary Structure-Activity-Relationship study of the MMV Pathogen Box compound MMV675968 (2,4-diaminoquinazoline) unveils novel inhibitors of Trypanosoma brucei brucei DHFR enzyme;2022-05-20

4. Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020;Journal of Medical Entomology;2022-02-08

5. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study;PLOS Neglected Tropical Diseases;2021-11-08